Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of 复方薏薢颗粒 for non-acute gout-related hyperuricemia
CTR20240360Phase 2Active
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- May 2024
- Countries
- 1
01
Overview
A Phase 2 trial of 复方薏薢颗粒 in hyperuricemia, gout, sponsored by Shanghai University of Traditional Chinese Medicine. Started May 2024; status: active.
02
Drugs
复方薏薢颗粒
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20240360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240360.